← Back to all signals
RESEARCH PAPER ANALYSIS

PIVKA-II combined with alpha-fetoprotein for the diagnostic value of hepatic tumors in children: a multicenter, prospective observational study.

AI interpretation is pending for this paper.

Open original publication →
PMID38622445
JournalHepatology international
Publication Date2024-04-16
Ingested2026-08-02 12:02 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: To investigate whether protein induced by vitamin K antagonist-II (PIVKA-II) combined with alpha-fetoprotein (AFP) can improve the diagnostic and differential diagnostic accuracy of childhood hepatic tumors. METHODS: A multi-center prospective observational study was performed at nine regional institutions around China. Children with hepatic mass (Group T) were divided into hepatoblastoma group (Group THB) and hemangioendothelioma group (Group THE), children with extrahepatic abdominal mass (Group C). Peripheral blood was collected from each patient prior to surgery or chemotherapy. The area under the curve (AUROC) was used to evaluate the diagnostic efficiency of PIVKA-II and the combined tumor markers with AFP. RESULTS: The mean levels of PIVKA-II and AFP were both significantly higher in Group T than Group C (p = 0.001, p < 0.001), in Group THB than Group THE (p = 0.018, p = 0.013) and in advanced HB than non-advanced HB (p = 0.001, p = 0.021). For the diagnosis of childhood hepatic tumors, AUROC of PIVKA-II (cut-off value 32.6 mAU/mL) and AFP (cut-off value 120 ng/mL) was 0.867 and 0.857. The differential diagnostic value of PIVKA-II and AFP in hepatoblastoma from hemangioendothelioma was further assessed, AUROC of PIVKA-II (cut-off value 47.1mAU/mL) and AFP (cut-off value 560 ng/mL) was 0.876 and 0.743. The combined markers showed higher AUROC (0.891, 0.895 respectively) than PIVKA-II or AFP alone. CONCLUSIONS: The serum level of PIVKA-II was significantly higher in children with hepatic tumors, especially those with malignant tumors. The combination of PIVKA-II with AFP further increased the diagnostic performance. TRIAL REGISTRATION: Clinical Trials, NCT03645655. Registered 20 August 2018, https://www. CLINICALTRIALS: gov/ct2/show/NCT03645655 .

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Beginning Restorative Activities Very Early: A Quality Improvement Project to Advance ABCDEF Bundle Practice in a Pediatric Oncology Intensive Care Unit. Pediatric reports 63.9 2 Developing Odontoma with Radiolucency in the Maxillary Right Second Molar. Reports (MDPI) 56.4 3 A New Horizon: Expanding the Access and Impact of Psychosocial Oncology-8-9 June 2026, 41st Annual CAPO Conference. Current oncology (Toronto, Ont.) 61.9 4 The Cervical Cancer Paradox in Eastern Europe: How Knowledge and Institutional Trust Shape HPV Vaccination Attitudes in Romania. Medical sciences (Basel, Switzerland) 59.5 5 Building Physician Capacity for HPV Vaccine Uptake in India: Mixed-Methods Implementation Outcomes of a Train-the-Trainer Model Using RE-AIM. Vaccines 61.4 6 The Interplay of Quality of Life and Satisfaction with Nursing Care in Cancer Patients: A Narrative Review. Clinics and practice 58.2 7 A Temporal Candidemia Cluster in a Jordanian Pediatric Oncology Unit: Clinical Characterization, Putative Environmental Sources, and Multidisciplinary Infection Control Responses-A Single-Center Pilot Study. Journal of fungi (Basel, Switzerland) 67.02 8 Clinical Characteristics and Outcomes of Surgical Treatment of Solitary Osteochondromas in Children: A 11-Year Retrospective Study. Medical sciences (Basel, Switzerland) 69.24 9 Assessment of the Environmental Impact of Uranium Mining Sites: A Case Study of a Uranium Deposit in Southern Kazakhstan. Toxics 57.5 10 Intra-Axial Cerebral Schwannoma in a Child: A Case Report. Neurology international 47.5 11 Age-Specific Radiological Risk of 222Rn in Drinking Water Wells Along the Sultandağı Fault Zone (Türkiye): A One-Year Monitoring Study. Toxics 57.2 12 Robotic approach for Wilms' tumour: Patient selection, technical considerations, and outcome analysis. Journal of pediatric urology 61.9 13 Stridor and Dysphagia Unmasking an Aberrant Right Subclavian Artery in a Toddler. Clinical practice and cases in emergency medicine 61.9 14 Knowledge, Attitudes, and Practices (KAP) Regarding Sexually Transmitted Infections, Human Papillomavirus, and HPV-Related Oropharyngeal Cancer Among Italian Adolescents: A Cross-Sectional Study. Dentistry journal 61.0 15 Myeloid/Lymphoid Neoplasm with FGFR1::ZMYM2 Rearrangement Presenting as T-Cell Acute Lymphoblastic Lymphoma with Concurrent Myeloproliferative Neoplasm: A Case Report. Hematology reports 61.0 16 Factors Affecting Temporal Changes in Ablated Liver Volume After Radiofrequency Ablation for Hepatocellular Carcinoma Evaluated by Three-Dimensional Volumetric Computed Tomography. Tomography (Ann Arbor, Mich.) 59.5 17 Bibliometric Analysis of Whole-Body MRI from 2015 to 2025 Across Clinical Applications, Quantitative Imaging, and Artificial Intelligence. Journal of imaging 56.0 18 Case Report: Clinical analysis and literature review of two cases of high-grade adult-type cervical embryonal rhabdomyosarcoma. Frontiers in oncology 62.3 19 Integrin β1 signaling at the crossroads of cellular plasticity, the tumor microenvironment, and therapy resistance in medulloblastoma. Frontiers in oncology 64.44 20 Real-World Data on Characteristics and Management of Patients with Actinic Keratosis: A Cancer Center Experience. Medical sciences (Basel, Switzerland) 70.1 21 Real-World Evidence of Disproportionate Financial Toxicity and Health-Related Social Needs Among Adolescents and Young Adults Receiving Care at an NCI-Designated Cancer Center. Current oncology (Toronto, Ont.) 70.62 22 Anticancer Activity of Green Synthesized ZnO Nanoparticles from Ficus benghalensis Bark in Osteosarcoma Cells. Nanomaterials (Basel, Switzerland) 56.9 23 Deep learning segmentation of paediatric brain tumours using diffusion-weighted MRI: towards an early, in vivo classification pipeline. Brain communications 62.5 24 Genomic Characterization of Epigenetic Regulator Gene Alterations in Juvenile Myelomonocytic Leukemia Through Whole-Exome Sequencing. Epigenomes 61.5 25 Exploring the Social and Stigma-Related Lived Experiences of Pediatric Cancer Survivors in a Canadian Province. Current oncology (Toronto, Ont.) 68.0 26 Knowledge, Attitudes, and Practices Related to Radiotherapy and Chemotherapy Among Women with Cervical Cancer: A Cross-Sectional Study. Journal of multidisciplinary healthcare 71.24 27 Radiological Findings and Genetic Rearrangements in Paediatric Patients with Acute Lymphoblastic Leukaemia. The application of clinical genetics 67.0 28 Comparison of clinical characteristics between children and adults with adrenal mass. Discover oncology 68.0 29 The quiet flame: whole-body MRI and the underestimated burden of pediatric chronic non-bacterial osteomyelitis (CNO). European journal of pediatrics 65.0 30 Radiological hazard assessment of radionuclides in packaged non-alcoholic beverages commonly consumed in Türkiye. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 58.7 31 Machine Learning Modeling for Predicting Mortality in Pediatric Patients Undergoing Elective Noncardiac Surgery: Comparison to a Regression Model. Anesthesia and analgesia 71.0 32 Exchange transfusion and systemic corticosteroid therapy for transient abnormal myelopoiesis in patients with Down syndrome: a report from the JCCG TAM-10 trial. European journal of pediatrics 69.14
PATIENT-FRIENDLY SUMMARY

PIVKA-II combined with alpha-fetoprotein for the diagnostic value of hepatic tumors in children: a multicenter, prospective observational study.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic